Page 38 - Pharma
Sanofi launches Made in India ShanIPV polio vaccine
Shantha Biotechnics, an affiliate of Sanofi Pasteur, is the first Indian company to supply injectable inactivated polio vaccine (IPV) via UNICEF to the Indian Government
 "Sanofi launches Made in India ShanIPV polio vaccine")
Sun Pharma receives US FDA nod for generic Gleevec
The company, being the first-to-file an ANDA for generic Gleevec (imatinib mesylate) with a para IV certification, is eligible for 180-days marketing exclusivity in the US
 "Sun Pharma receives US FDA nod for generic Gleevec")
Ajanta Pharma launches asthma drug montelukast in US
The company launched montelukast sodium immediate-release (IR) and chewable tablets, generic version of Merck's Singulair
Sequent Scientific arm Alivira buys three companies in Europe
With these acquisitions, N-Vet AB, Fendigo SA and Fendigo BV, the company has forayed into European veterinary markets of Sweden, Belgium, Netherlands and Luxemburg
 "Sequent Scientific arm Alivira buys three companies in Europe")
AstraZeneca to shut down API unit in Bengaluru
This follows the company decision to stop the production of terbutaline sulphate - the only product being manufactured at the API unit
 "AstraZeneca to shut down API unit in Bengaluru")
US FDA grants approval to Aurobindo Pharma's osteoporosis drug risedronate
The approved product has an estimated market size of $ 113 million for the twelve months ending October 2015, according to IMS
Cipla to launch low-dose efavirenz combination drugs for HIV
Reducing the dose of efavirenz in current first-line combination therapy will contribute to reducing costs without modifying the effectiveness of treatment, says the company
 "Cipla to launch low-dose efavirenz combination drugs for HIV")
Jubilant Life receives US FDA nod for antidepressant drug paroxetine
Paroxetine tablet is a generic version of Apotex's Paxil tablet
Indian pharma machinery market to reach $ 1.78 bn by 2020
Exports is expected to account for 72 percent of the total pharma production and reach a value of $ 40 billion by 2020, says a report of UBM India and AGR Knowledge Services
 "Indian pharma machinery market to reach $ 1.78 bn by 2020")
Swiss firm Clariant to set up healthcare packaging plant in Tamil Nadu
The new plant, to be built with an investment of CHF 10 million (about Rs 64 crore), will produce moisture-control products such as desiccant, adsorbent polymers, etc
 "Swiss firm Clariant to set up healthcare packaging plant in Tamil Nadu")
Govt to create inventory of chemicals in India
CII takes first step towards the national chemicals inventory by launching ChemStreet and ChemSource, which aim to be a repository of information on chemicals in the country
 "Govt to create inventory of chemicals in India")
Novo Nordisk to use renewable energy at all global production plants by 2020
Switching to renewable electricity makes sense from both a climate and a cost perspective, says the company
 "Novo Nordisk to use renewable energy at all global production plants by 2020")
Thermo Fisher opens GMP clinical services facility in Singapore
The new biopharma services hub will offer larger operational space and advanced equipment to meet increasing clinical supply needs for pharma and biotech customers
UK's Research Councils and India's DBT to collaborate on climate change
Department of Biotechnology-RCUK joint research programmes have been contributing towards cutting edge research in the areas of life sciences, biotechnology, etc
 "UK's Research Councils and India's DBT to collaborate on climate change")
US FDA approves Aurobindo Pharma's hypertension drug sildenafil
Sildenafil tablet, a generic version of Pfizer's Revatio tablet, has an estimated market size of $ 80 million for the twelve months ending September 2015
Sequent Scientific arm Alivira buys Turkey-based Topkim for Rs 46 cr
The acquisition will consolidate Alivira's presence in the $ 400 million Turkish veterinary market and make it the largest animal health company in Turkey
Pfizer and Allergan agree to merge in a $ 160-bn deal
The combined company is expected to generate annual operating cash flow in excess of $25 billion beginning in 2018
 "Pfizer and Allergan agree to merge in a $ 160-bn deal")
Zydus Cadila launches diabetic drug teneligliptin
Branded as Tenglyn, the company claims that it is the most affordable gliptin (a new class of oral anti-diabetic agents) for diabetics in India
South African university and Merck to co-develop malaria drug
Research collaboration will combine Merck's R&D expertise and the drug discovery capabilities of the University of Cape Town
Merck aims to more than double sales in Africa by 2020
The company, which expects to clock Euro 200 million in sales in 2015, targets Euro 500 million in sales from the African region by 2020